R) Reported To Be Safe And Effective In Study Published In European Journal Of...
XclairMedical News Today: 7 views since Wednesday, July 9, 2008 at 08:23 AM
ALIGN Pharmaceuticals, LLC, a wholly owned subsidiary of Cyclacel Pharmaceuticals, Inc., (NASDAQ: CYCC, CYCCP) announced results of a double-blinded, randomized, vehicle-controlled clinical study showing that Xclair® cream (formerly MAS065D) is safe and effective in the treatment and prevention of radiation dermatitis.

Published in: Randomized Things